Pages
(Move to ...)
Home
▼
Monday, October 03, 2011
No Glass Ceilings: Medtech Women Gather at Unique Industry Meet-Up
›
MedtechWOMEN co-founders Amy Belt and Deborah Kilpatrick Something new happened in the medical device world two weeks ago. It wasn'...
Insulin Pricing: Let The Battles Begin
›
In the same week that Novo Nordisk filed its latest-generation insulins, ultra-long-acting Degludec and the DegludecPlus combo, in Europe an...
Friday, September 30, 2011
Deals Of The Week: It's All About Access
›
One of the week's most interesting news events came from across the pond as the International Structural Genomics Consortium (SGC) made ...
Thursday, September 29, 2011
Financings of The Fortnight Has No Clue What Will Happen Next
›
Some people call it "risk/reward ratio." Some people call it "systemic uncertainty." But in the spirit of basebal...
4 comments:
Friday, September 23, 2011
Deals of the Week Plays
Moneyball
›
Sometimes picking a winner is easy. But if you ask a baseball general manager, a moviegoer, or a private eq...
Wednesday, September 21, 2011
Professional Egos, Cultural Norms Clash At Xarelto AdComm
›
Let’s be honest – we look forward to some FDA advisory committee meetings more than others. Some meetings, such as those convened only becau...
Tuesday, September 20, 2011
At PSA: Thinking Primarily About Primary Care Rx
›
Has the life gone out of primary care drug market? Referring to the category as “dead” is hardly a jaw dropping comment in today's marke...
Friday, September 16, 2011
Deals of the Week: Riding in Cars with Pharma
›
Move over Lewis Hamilton and Jenson Button ? GlaxoSmithKline said yesterday that it had partnered with the McLaren Group , the British Form...
Financings of the Fortnight Welcomes All Ye Who Enter Here
›
By our measure, at least five new health-care funds debuted or made news in recent days. Count with us: 1) Longitude Capital Management...
1 comment:
Thursday, September 15, 2011
Merck's $500 Million Venture Bet -- Industry's Latest and Largest Attempt to Get Closer to VCs
›
Today in the newly released September issue of IN VIVO we're reporting that Merck & Co., until recently one of the few large pharma...
1 comment:
‹
›
Home
View web version